A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck
NCT00203905
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
23
Enrollment
OTHER
Sponsor class
Conditions
Head and Neck Cancer
Interventions
DRUG:
5-Fluorouracil, Hydroxyurea-[FHX], Bevacizumab
DRUG:
5-Fluorouracil, Hydroxyurea-[FHX]
Sponsor
University of Chicago